Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pseudotumor Cerebri | 8 | 2021 | 108 | 3.240 |
Why?
|
Papilledema | 5 | 2018 | 130 | 1.630 |
Why?
|
Intracranial Hypertension | 4 | 2021 | 193 | 1.360 |
Why?
|
Chorionic Gonadotropin | 2 | 2022 | 457 | 1.350 |
Why?
|
Lymphadenitis | 1 | 2024 | 99 | 0.870 |
Why?
|
Optic Nerve | 2 | 2016 | 572 | 0.510 |
Why?
|
Adenocarcinoma | 2 | 2024 | 6345 | 0.510 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2024 | 1640 | 0.420 |
Why?
|
Visual Fields | 2 | 2016 | 1062 | 0.400 |
Why?
|
Carrier Proteins | 1 | 2024 | 4937 | 0.360 |
Why?
|
Pons | 1 | 2011 | 240 | 0.360 |
Why?
|
Prostatic Neoplasms | 2 | 2024 | 11122 | 0.360 |
Why?
|
Ocular Motility Disorders | 1 | 2011 | 144 | 0.350 |
Why?
|
Diplopia | 1 | 2011 | 214 | 0.350 |
Why?
|
Visual Acuity | 5 | 2018 | 2672 | 0.330 |
Why?
|
Cerebrospinal Fluid Pressure | 2 | 2019 | 38 | 0.310 |
Why?
|
RNA Helicases | 1 | 2024 | 144 | 0.210 |
Why?
|
Fundus Oculi | 3 | 2020 | 556 | 0.210 |
Why?
|
Lymph Nodes | 2 | 2024 | 3465 | 0.190 |
Why?
|
Intracranial Pressure | 2 | 2021 | 324 | 0.190 |
Why?
|
Skull Base | 2 | 2021 | 292 | 0.180 |
Why?
|
Headache | 2 | 2020 | 1256 | 0.180 |
Why?
|
Herpes Simplex | 1 | 2024 | 478 | 0.180 |
Why?
|
Eye Diseases | 2 | 2020 | 653 | 0.170 |
Why?
|
Optic Neuritis | 1 | 2022 | 174 | 0.170 |
Why?
|
DNA Helicases | 1 | 2024 | 851 | 0.160 |
Why?
|
NADH Dehydrogenase | 1 | 2018 | 47 | 0.150 |
Why?
|
Carcinoma in Situ | 1 | 2024 | 791 | 0.150 |
Why?
|
Brain Ischemia | 1 | 2011 | 3049 | 0.150 |
Why?
|
Receptors, Androgen | 1 | 2024 | 1079 | 0.150 |
Why?
|
Optic Atrophy, Hereditary, Leber | 1 | 2018 | 50 | 0.150 |
Why?
|
Ophthalmoscopy | 2 | 2018 | 171 | 0.140 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2024 | 783 | 0.140 |
Why?
|
Sequence Deletion | 2 | 2012 | 1494 | 0.140 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2018 | 251 | 0.130 |
Why?
|
Lymph Node Excision | 1 | 2022 | 1271 | 0.130 |
Why?
|
Ischemic Attack, Transient | 1 | 2021 | 882 | 0.130 |
Why?
|
Vision Disorders | 3 | 2022 | 1088 | 0.130 |
Why?
|
Photography | 1 | 2018 | 532 | 0.130 |
Why?
|
Databases, Bibliographic | 1 | 2015 | 130 | 0.130 |
Why?
|
Humans | 31 | 2024 | 761596 | 0.120 |
Why?
|
Depth Perception | 1 | 2015 | 94 | 0.120 |
Why?
|
Stroke | 2 | 2021 | 9758 | 0.120 |
Why?
|
Androgen Antagonists | 1 | 2024 | 1410 | 0.120 |
Why?
|
Retrospective Studies | 10 | 2024 | 80647 | 0.120 |
Why?
|
Vision Tests | 1 | 2015 | 161 | 0.120 |
Why?
|
Blindness | 1 | 2018 | 584 | 0.120 |
Why?
|
Lymphatic Metastasis | 1 | 2022 | 2915 | 0.120 |
Why?
|
Brain | 3 | 2016 | 27121 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2024 | 2827 | 0.120 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2015 | 173 | 0.110 |
Why?
|
Vision, Binocular | 1 | 2015 | 226 | 0.110 |
Why?
|
Body Height | 1 | 2020 | 1570 | 0.110 |
Why?
|
Optic Disk | 1 | 2018 | 421 | 0.110 |
Why?
|
Repressor Proteins | 1 | 2024 | 2986 | 0.110 |
Why?
|
Dependovirus | 1 | 2018 | 718 | 0.100 |
Why?
|
Male | 19 | 2024 | 360846 | 0.100 |
Why?
|
Proteostasis Deficiencies | 1 | 2012 | 39 | 0.100 |
Why?
|
Outpatients | 1 | 2020 | 1597 | 0.100 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2024 | 2223 | 0.090 |
Why?
|
Rhodopsin | 1 | 2012 | 203 | 0.090 |
Why?
|
Trypan Blue | 1 | 2010 | 22 | 0.090 |
Why?
|
Rosaniline Dyes | 1 | 2010 | 50 | 0.090 |
Why?
|
Female | 19 | 2022 | 392705 | 0.090 |
Why?
|
Pilot Projects | 1 | 2024 | 8633 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2024 | 12973 | 0.090 |
Why?
|
Triamcinolone Acetonide | 1 | 2010 | 100 | 0.090 |
Why?
|
Body Weight | 1 | 2020 | 4618 | 0.080 |
Why?
|
Dyslexia | 1 | 2011 | 208 | 0.080 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2850 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5799 | 0.080 |
Why?
|
Perceptual Disorders | 1 | 2011 | 198 | 0.080 |
Why?
|
Comparative Genomic Hybridization | 1 | 2010 | 473 | 0.080 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2010 | 361 | 0.080 |
Why?
|
Middle Aged | 12 | 2022 | 220921 | 0.080 |
Why?
|
Indocyanine Green | 1 | 2010 | 233 | 0.080 |
Why?
|
Self Report | 1 | 2020 | 3725 | 0.080 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2011 | 359 | 0.080 |
Why?
|
Retinitis Pigmentosa | 1 | 2012 | 397 | 0.080 |
Why?
|
Genetic Vectors | 1 | 2018 | 3396 | 0.080 |
Why?
|
Marfan Syndrome | 1 | 2010 | 236 | 0.080 |
Why?
|
Coloring Agents | 1 | 2010 | 562 | 0.070 |
Why?
|
Prognosis | 3 | 2024 | 29629 | 0.070 |
Why?
|
Neoplasm Staging | 1 | 2022 | 11120 | 0.070 |
Why?
|
Uveitis | 1 | 2011 | 395 | 0.070 |
Why?
|
Sclerostomy | 1 | 2007 | 16 | 0.070 |
Why?
|
Space Perception | 1 | 2011 | 465 | 0.070 |
Why?
|
Ophthalmology | 1 | 2014 | 550 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2022 | 3222 | 0.070 |
Why?
|
Syphilis | 1 | 2010 | 243 | 0.070 |
Why?
|
Teaching | 1 | 2014 | 1170 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 36426 | 0.060 |
Why?
|
Trabeculectomy | 1 | 2007 | 174 | 0.060 |
Why?
|
Microfilament Proteins | 1 | 2010 | 1134 | 0.060 |
Why?
|
Education, Medical, Undergraduate | 1 | 2014 | 1070 | 0.060 |
Why?
|
Endothelium, Corneal | 1 | 2007 | 215 | 0.060 |
Why?
|
Abnormalities, Multiple | 1 | 2011 | 1423 | 0.050 |
Why?
|
Retina | 2 | 2011 | 2659 | 0.050 |
Why?
|
Thrombocytopenia | 1 | 2011 | 1182 | 0.050 |
Why?
|
Electroretinography | 2 | 2018 | 525 | 0.050 |
Why?
|
Adult | 11 | 2020 | 221210 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3779 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2018 | 7879 | 0.050 |
Why?
|
Risk Assessment | 1 | 2022 | 23996 | 0.050 |
Why?
|
Base Sequence | 1 | 2012 | 12441 | 0.050 |
Why?
|
Students, Medical | 1 | 2014 | 1936 | 0.040 |
Why?
|
Glaucoma, Open-Angle | 1 | 2007 | 738 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14665 | 0.040 |
Why?
|
Attention | 1 | 2011 | 2396 | 0.040 |
Why?
|
France | 2 | 2012 | 497 | 0.040 |
Why?
|
Microsatellite Repeats | 2 | 2012 | 784 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 9001 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2011 | 4176 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15843 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4793 | 0.040 |
Why?
|
Color Vision | 1 | 2018 | 23 | 0.040 |
Why?
|
Urinary Bladder | 1 | 2024 | 1152 | 0.040 |
Why?
|
Body Mass Index | 1 | 2015 | 12953 | 0.040 |
Why?
|
Aged | 5 | 2022 | 169310 | 0.030 |
Why?
|
Contrast Sensitivity | 1 | 2018 | 253 | 0.030 |
Why?
|
Intravitreal Injections | 1 | 2018 | 385 | 0.030 |
Why?
|
Phenotype | 2 | 2011 | 16592 | 0.030 |
Why?
|
Evoked Potentials, Visual | 1 | 2018 | 417 | 0.030 |
Why?
|
Adolescent | 5 | 2015 | 88326 | 0.030 |
Why?
|
Tomography, Optical Coherence | 2 | 2022 | 2917 | 0.030 |
Why?
|
Physical Examination | 1 | 2020 | 1255 | 0.030 |
Why?
|
Prospective Studies | 4 | 2022 | 54423 | 0.030 |
Why?
|
Pedigree | 2 | 2012 | 4542 | 0.030 |
Why?
|
Retinal Diseases | 1 | 2018 | 705 | 0.030 |
Why?
|
Neurology | 1 | 2020 | 780 | 0.020 |
Why?
|
Transformation, Genetic | 1 | 2012 | 192 | 0.020 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2011 | 228 | 0.020 |
Why?
|
Receptors, Interleukin-6 | 1 | 2011 | 225 | 0.020 |
Why?
|
Neurosyphilis | 1 | 2010 | 27 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2010 | 427 | 0.020 |
Why?
|
DNA Probes | 1 | 2010 | 541 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2012 | 852 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5247 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2010 | 553 | 0.020 |
Why?
|
Vitreous Body | 1 | 2010 | 399 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39106 | 0.020 |
Why?
|
Macular Edema | 1 | 2011 | 374 | 0.020 |
Why?
|
Injections | 1 | 2010 | 831 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2508 | 0.020 |
Why?
|
Plasmids | 1 | 2012 | 2269 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2012 | 2341 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2011 | 1386 | 0.020 |
Why?
|
Exons | 1 | 2012 | 2391 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14608 | 0.020 |
Why?
|
Sclera | 1 | 2007 | 190 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2010 | 1202 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 26129 | 0.020 |
Why?
|
Phacoemulsification | 1 | 2007 | 149 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2007 | 15633 | 0.010 |
Why?
|
Syndrome | 1 | 2011 | 3267 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2510 | 0.010 |
Why?
|
Child | 4 | 2015 | 80158 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 74213 | 0.010 |
Why?
|
HIV Infections | 1 | 2010 | 17354 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13255 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1835 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2011 | 1882 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 1881 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2010 | 1964 | 0.010 |
Why?
|
Telemedicine | 1 | 2018 | 3052 | 0.010 |
Why?
|
Intraocular Pressure | 1 | 2007 | 1294 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4740 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6075 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4352 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 8181 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17635 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41495 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15601 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2011 | 7054 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20100 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2015 | 58984 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10508 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23741 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2012 | 22176 | 0.010 |
Why?
|
United States | 1 | 2018 | 72340 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 59260 | 0.000 |
Why?
|
Mutation | 1 | 2010 | 30053 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2011 | 64685 | 0.000 |
Why?
|
Animals | 1 | 2010 | 168475 | 0.000 |
Why?
|
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_